Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts
Jean Albrengues, Thomas Bertero, Eloïse M. Grasset, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 320

Showing 1-25 of 320 citing articles:

The biology and function of fibroblasts in cancer
Raghu Kalluri
Nature reviews. Cancer (2016) Vol. 16, Iss. 9, pp. 582-598
Closed Access | Times Cited: 3414
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai, Igor Astsaturov, Edna Cukierman, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 3, pp. 174-186
Open Access | Times Cited: 2733
Turning foes to friends: targeting cancer-associated fibroblasts
Xueman Chen, Erwei Song
Nature Reviews Drug Discovery (2018) Vol. 18, Iss. 2, pp. 99-115
Closed Access | Times Cited: 1405
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Xiaoqi Mao, Jin Xu, Wei Wang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 1364
IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Giulia Biffi, Tobiloba E. Oni, Benjamin Spielman, et al.
Cancer Discovery (2018) Vol. 9, Iss. 2, pp. 282-301
Open Access | Times Cited: 988
Targeting the tumour stroma to improve cancer therapy
Kenneth C. Valkenburg, Amber E. de Groot, Kenneth J. Pienta
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 6, pp. 366-381
Open Access | Times Cited: 896
Diversity and Biology of Cancer-Associated Fibroblasts
Giulia Biffi, David A. Tuveson
Physiological Reviews (2020) Vol. 101, Iss. 1, pp. 147-176
Open Access | Times Cited: 812
Targeting STAT3 in Cancer Immunotherapy
Sailan Zou, Qiyu Tong, Bowen Liu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 704
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Tongyan Liu, Chencheng Han, Siwei Wang, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 702
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
Philippe Gascard, Thea D. Tlsty
Genes & Development (2016) Vol. 30, Iss. 9, pp. 1002-1019
Open Access | Times Cited: 644
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale, Efrat Shema, Sherene Loi, et al.
Nature Medicine (2021) Vol. 27, Iss. 2, pp. 212-224
Closed Access | Times Cited: 561
A peek into cancer-associated fibroblasts: origins, functions and translational impact
Valerie S. LeBleu, Raghu Kalluri
Disease Models & Mechanisms (2018) Vol. 11, Iss. 4
Open Access | Times Cited: 469
Epigenetic therapy in immune-oncology
Peter A. Jones, Hitoshi Ohtani, Ankur Chakravarthy, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 3, pp. 151-161
Closed Access | Times Cited: 449
Cancer-associated fibroblasts in gastrointestinal cancer
Hiroki Kobayashi, Atsushi Enomoto, Susan L. Woods, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 5, pp. 282-295
Closed Access | Times Cited: 446
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Fanglong Wu, Jin Yang, Junjiang Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 443
Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map
Jennifer Huynh, Ashwini L. Chand, Daniel J. Gough, et al.
Nature reviews. Cancer (2018) Vol. 19, Iss. 2, pp. 82-96
Closed Access | Times Cited: 441
Fibroblasts as immune regulators in infection, inflammation and cancer
Sarah Davidson, Mark Coles, Tom Thomas, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 704-717
Open Access | Times Cited: 374
Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy
Thomas Bertero, William M. Oldham, Eloïse M. Grasset, et al.
Cell Metabolism (2018) Vol. 29, Iss. 1, pp. 124-140.e10
Open Access | Times Cited: 311
Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review
Shreya Thakkar, Dilip Kumar Sharma, Kiran Kalia, et al.
Acta Biomaterialia (2019) Vol. 101, pp. 43-68
Closed Access | Times Cited: 272
Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment
Luke Bu, Hideo Baba, Naoya Yoshida, et al.
Oncogene (2019) Vol. 38, Iss. 25, pp. 4887-4901
Closed Access | Times Cited: 269
Fibroblast activation in cancer: when seed fertilizes soil
Sanya-Eduarda Kužet, Cédric Gaggioli
Cell and Tissue Research (2016) Vol. 365, Iss. 3, pp. 607-619
Closed Access | Times Cited: 245
Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance
Phillip M. Galbo, Xingxing Zang, Deyou Zheng
Clinical Cancer Research (2021) Vol. 27, Iss. 9, pp. 2636-2647
Open Access | Times Cited: 237
Fibroblasts in the Tumor Microenvironment: Shield or Spear?
Twana Alkasalias, Lidia Moyano‐Galceran, Marie Arsenian‐Henriksson, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1532-1532
Open Access | Times Cited: 220
Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways
Go J. Yoshida
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 220
Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer
Lisa M. Becker, Joyce T. O’Connell, Annie P. Vo, et al.
Cell Reports (2020) Vol. 31, Iss. 9, pp. 107701-107701
Open Access | Times Cited: 218
Page 1 - Next Page

Scroll to top